Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

BACKGROUND: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has a wide range of effects on glucose metabolism and cardiovascular function (e.g., improving insulin sensitivity, reduction in appetite, modulation of heart rate, blood pressure and myocardial contractility). Metabolic syndrom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yamaoka-Tojo, Minako, Tojo, Taiki, Takahira, Naonobu, Matsunaga, Atsuhiko, Aoyama, Naoyoshi, Masuda, Takashi, Izumi, Tohru
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2010
Schlagworte:
Original investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2891690/
https://ncbi.nlm.nih.gov/pubmed/20470376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-9-17
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge